ArticleAntimicrobial agents and chemotherapy2015

Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide.

Ronald N Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.